thalidomide has been researched along with Jaw Diseases in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Jaw Diseases: Diseases involving the JAW.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dimopoulos, MA | 1 |
Kastritis, E | 1 |
Bamia, C | 1 |
Melakopoulos, I | 1 |
Gika, D | 1 |
Roussou, M | 1 |
Migkou, M | 1 |
Eleftherakis-Papaiakovou, E | 1 |
Christoulas, D | 1 |
Terpos, E | 1 |
Bamias, A | 1 |
Tosi, P | 1 |
Zamagni, E | 1 |
Cangini, D | 1 |
Tacchetti, P | 1 |
Di Raimondo, F | 1 |
Catalano, L | 1 |
D'Arco, A | 1 |
Ronconi, S | 1 |
Cellini, C | 1 |
Offidani, M | 1 |
Perrone, G | 1 |
Ceccolini, M | 1 |
Brioli, A | 1 |
Tura, S | 1 |
Baccarani, M | 1 |
Cavo, M | 1 |
Stoopler, ET | 1 |
Vogl, DT | 1 |
Stadtmauer, EA | 1 |
1 trial available for thalidomide and Jaw Diseases
Article | Year |
---|---|
Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Dexamethasone; Dip | 2006 |
2 other studies available for thalidomide and Jaw Diseases
Article | Year |
---|---|
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Density Conservation Agents; Boronic Aci | 2009 |
Medical management update: multiple myeloma.
Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Combined | 2007 |